Patents by Inventor Christopher D. Creech

Christopher D. Creech has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for identifying modulators of cyclic nucleotide-gated cation channels
    Patent number: 7514208
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: April 7, 2009
    Assignee: ICAgen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • CNG2B: A NOVEL HUMAN CYCLIC NUCLEOTIDE-GATED ION CHANNEL
    Publication number: 20080145943
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Application
    Filed: April 17, 2007
    Publication date: June 19, 2008
    Applicant: ICAgen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • Cyclic nucleotide-gated cation channel subunit 3B (CNG3B) polypeptides
    Patent number: 7371823
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG3B, antibodies to CNG3B, methods of detecting CNG3B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG3B. The invention further provides, in a computer system, a method of screening for mutations of human CNG3B genes as well as a method for identifying a three-dimensional structure of human CNG3B polypeptides.
    Type: Grant
    Filed: October 23, 2006
    Date of Patent: May 13, 2008
    Assignee: Icagen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • Isolated nucleic acids encoding cyclic nucleotide-gated cation channel subunit 3B (CNG3B) polypeptides
    Patent number: 7141419
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG3B, antibodies to CNG3B, methods of detecting CNG3B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG3B. The invention further provides, in a computer system, a method of screening for mutations of human CNG3B genes as well as a method for identifying a three-dimensional structure of human CNG3B polypeptides.
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: November 28, 2006
    Assignee: Icagen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • Human cyclic nucleotide-gated cation channel polypeptide
    Patent number: 7053183
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: May 30, 2006
    Assignee: Icagen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • Human cyclic nucleotide-gated channel polypeptide
    Patent number: 6933147
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Grant
    Filed: August 10, 2001
    Date of Patent: August 23, 2005
    Assignee: ICAgen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • CNG3B: a novel cyclic nucleotide-gated cation channel
    Publication number: 20040137433
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG3B, antibodies to CNG3B, methods of detecting CNG3B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG3B. The invention further provides, in a computer system, a method of screening for mutations of human CNG3B genes as well as a method for identifying a three-dimensional structure of human CNG3B polypeptides.
    Type: Application
    Filed: May 14, 2001
    Publication date: July 15, 2004
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • CNG2B: a novel human cyclic nucleotide-gated ion channel
    Publication number: 20020182691
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Application
    Filed: August 10, 2001
    Publication date: December 5, 2002
    Applicant: ICAgen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla